Protein

N501Y mutation in SARS-CoV-2 responsible for increased viral transmission

It may be possible to delay the second dose of the Pfizer-BioNTech SARS-CoV-2 vaccine in some cases.

A recently discovered cellular weight enzyme may be a target for the treatment of neurodegenerative disease

Researchers are discovering new proteins that may play a key role in atherosclerosis

Nanobody works against all variants of SARS-CoV-2 stress in an animal model

Newly detected bat corona virus 94.5% equivalent to SARS-CoV-2

Genome-wide covariation analysis sheds light on the evolution of SARS-CoV-2

Mosquito protein analysis could lead to therapeutic treatment against deadly viruses

Neutral antibodies may be developed to keep up with SARS-CoV-2 mutations

Tiny antibodies produced by llamas may be effective against COVID-19